ZA908696B - Hetero cyclic pharmaceutical compounds preparation and use - Google Patents

Hetero cyclic pharmaceutical compounds preparation and use

Info

Publication number
ZA908696B
ZA908696B ZA908696A ZA908696A ZA908696B ZA 908696 B ZA908696 B ZA 908696B ZA 908696 A ZA908696 A ZA 908696A ZA 908696 A ZA908696 A ZA 908696A ZA 908696 B ZA908696 B ZA 908696B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compounds
hetero cyclic
compounds preparation
carbon atoms
cycloalkyl
Prior art date
Application number
ZA908696A
Other languages
English (en)
Inventor
James Leroy Kelley
Leroy Kelley James
David Lee Musso
Lee Musso David
Grady Evan Boswell
Evan Boswell Grady
Barrett Randolph Cooper
Randolph Cooper Barrett
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ZA908696B publication Critical patent/ZA908696B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA908696A 1989-10-31 1990-10-30 Hetero cyclic pharmaceutical compounds preparation and use ZA908696B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898924528A GB8924528D0 (en) 1989-10-31 1989-10-31 Heterocyclic pharmaceutical compounds,preparation and use

Publications (1)

Publication Number Publication Date
ZA908696B true ZA908696B (en) 1992-07-29

Family

ID=10665482

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA908696A ZA908696B (en) 1989-10-31 1990-10-30 Hetero cyclic pharmaceutical compounds preparation and use

Country Status (19)

Country Link
US (1) US5104870A (ja)
EP (1) EP0426416B1 (ja)
JP (1) JP2873076B2 (ja)
AT (1) ATE101604T1 (ja)
AU (1) AU645763B2 (ja)
CA (1) CA2028893C (ja)
DE (1) DE69006682T2 (ja)
DK (1) DK0426416T3 (ja)
ES (1) ES2062406T3 (ja)
FI (1) FI94753C (ja)
GB (1) GB8924528D0 (ja)
HU (2) HU207304B (ja)
IE (1) IE66115B1 (ja)
LV (1) LV11030B (ja)
MX (1) MX9203219A (ja)
NZ (1) NZ235882A (ja)
PT (1) PT95735B (ja)
SG (1) SG28347G (ja)
ZA (1) ZA908696B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9108629D0 (en) * 1991-04-23 1991-06-12 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use
AU1403899A (en) * 1997-11-14 1999-06-07 Glaxo Group Limited Method of treating addiction to nicotine products
MA26693A1 (fr) * 1998-09-28 2004-12-20 Glaxo Group Ltd Compositions pour administration par voie buccale
AU7750100A (en) * 1999-10-13 2001-04-23 Glaxo Group Limited Method for the treatment of obesity
JP4625637B2 (ja) 2002-02-22 2011-02-02 シャイア エルエルシー 活性物質送達系及び活性物質を保護し投与する方法
CA2635261A1 (en) * 2006-01-03 2007-07-12 Algebra, Inc. Therapeutic amine-arylsulfonamide conjugate compounds
EP2419400A1 (en) 2009-04-15 2012-02-22 Research Triangle Institute Monoamine reuptake inhibitors
JP2013526583A (ja) 2010-05-21 2013-06-24 リサーチ・トライアングル・インスティチュート フェニルモルホリンおよびその類似体
JP5952267B2 (ja) * 2010-05-21 2016-07-13 リサーチ・トライアングル・インスティチュート 薬物依存を処置するためのヒドロキシブプロピオン類似体(政府支援研究または開発)
CN105949142B (zh) * 2016-05-21 2018-03-27 南华大学 具有抗抑郁活性的单一手性化合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3117967A (en) * 1962-04-02 1964-01-14 Smith Kline French Lab 2-biphenylyl-2-hydroxy-morpholinium halides
FR2553413B1 (fr) * 1983-10-17 1986-03-21 Lafon Labor Derives de 4-alkyl-2-hydroxy-3-methyl-2-phenyl-morpholine, procede de preparation et utilisation en therapeutique
GB8417170D0 (en) * 1984-07-05 1984-08-08 Wellcome Found Heterocyclic pharmaceutical compounds

Also Published As

Publication number Publication date
SG28347G (en) 1995-09-18
PT95735A (pt) 1991-09-13
PT95735B (pt) 1998-01-30
MX9203219A (es) 1992-07-01
EP0426416A1 (en) 1991-05-08
AU6563990A (en) 1991-05-09
HU207304B (en) 1993-03-29
GB8924528D0 (en) 1989-12-20
LV11030B (en) 1996-08-20
JP2873076B2 (ja) 1999-03-24
DK0426416T3 (da) 1994-03-14
FI94753B (fi) 1995-07-14
AU645763B2 (en) 1994-01-27
IE903888A1 (en) 1991-05-08
FI94753C (fi) 1995-10-25
JPH03206084A (ja) 1991-09-09
IE66115B1 (en) 1995-12-13
CA2028893A1 (en) 1991-05-01
HUT57748A (en) 1991-12-30
ATE101604T1 (de) 1994-03-15
HU906935D0 (en) 1991-05-28
US5104870A (en) 1992-04-14
DE69006682D1 (de) 1994-03-24
ES2062406T3 (es) 1994-12-16
HU211304A9 (en) 1995-11-28
EP0426416B1 (en) 1994-02-16
NZ235882A (en) 1993-05-26
LV11030A (lv) 1996-02-20
DE69006682T2 (de) 1994-08-04
CA2028893C (en) 2000-10-10
FI905356A0 (fi) 1990-10-30

Similar Documents

Publication Publication Date Title
ZA897660B (en) Biologically active compounds
ES2071681T3 (es) Compuestos macrociclicos.
DE69201948T2 (de) Verwendung von 1,3-oxathiolanalogen von nukleosiden zur herstellung eines arzneimittels zur behandlung von hepatitis-b.
AU645763B2 (en) Hetero cyclic pharmaceutical compounds, preparation and use
DE68917772T2 (de) 2-Alkyl-3-benzoylbenzofurane und diese enthaltende pharmazeutische Zusammensetzungen.
ATE141605T1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen
DE3752272T2 (de) Verwendung eines Thioesters zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Ischämie und von Reperfusion-Syndromen
KR880007070A (ko) 백내장 치료용 약학 조성물
DE69017839T2 (de) NMDA-blockierende Verbindungen, pharmazeutische Präparate, deren Herstellung und Verwendung.
HUT51600A (en) Process for production of derivatives of sulphonanilid with effect decreasing of blood-pressure and medical compositions containing them as active substance
GB8608893D0 (en) D-nor-7-ergoline derivatives
KR930001906A (ko) 벤즈이미다졸린-2-옥소-1-카복실산 유도체의 용도